Vaccine Cold Chain in a Continental Country Brazil

Similar documents
Role of Partnerships in Developing Innovative Vaccines: Brazil

achievements, challenges and financing

Last mile vaccine distribution to rural health centres. Faheem Merchant

Programme update. Prequalification of Vaccines

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007

Heat and Freeze Sensitivity of Vaccines

UNICEF s perspective. WHO Informal Consultation to develop further guidance on vaccines for the UNEP-convened INC4 Geneva, 3-4 April 2012

Preventing Accidental Freezing in the Cold Chain. An introduction to cold chain freezing and some options for reducing it.

Global update on temperature monitoring

Managing constrained vaccine supply: prevention and remediation Lessons learned and ways forward DVCMN Annual Meeting October Bangkok,

CHILD REGISTRATION FORM

UNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013

A vaccine s journey: the many steps to saving lives

Status and challenges

Expanded Programme on Immunization (EPI):

Adolescent vaccination strategies

Thailand Expanded Program on Immunization. Suchada Jiamsiri, MD, MPH Division of Vaccine Preventable Diseases Ministry of Public Health, Thailand

Michel BAIJOT Vice President, WW Business Development & Strategic Alliances

Syrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation

Case Study: The Policy for the Introduction of New Vaccines in Brazil

Opportunities and challenges with introduction of newer vaccines: What is needed from the next generation of vaccines

Vaccine Storage in Remote Areas

This document was published by: The National Department of Health. Editorial team: Provincial EPI Team National EPI Team Dr NJ Ngcobo

How does Gavi make vaccine investment decisions?

Current National Immunisation Schedule Dr Brenda Corcoran National Immunisation Office.

Indicative operational, financial and environmental impact of Thiomersal-free vaccines

COMBINATION VACCINES: HOW AND WHY? LESSONS LEARNED.

Hepatitis B vaccination of newborns in rural China: evaluation of an out-of-coldchain delivery strategy. Istanbul, Turkey March 15-17, 2006

Quality assurance for essential medicines and health products: moving towards an harmonized approach

GAVI S VACCINE INVESTMENT STRATEGY

DCVMN VVM Overview Webinar

Case Studies on Monitoring the Heat and Freeze Sensitive of Vaccines

COMBINATION VACCINE - THE IMPORTANCE AND ROLE IN PUBLIC HEALTH SET UP

GAVI Alliance. Aurelia Nguyen, Director Policy & Market Shaping. IPC Meeting 30 May 2013

Immunization Update & focus on meningococcal vaccine PART 1

Requirements for new trials to examine offtarget. vaccination. Workshop on: Off-target (heterologous/non-specific) effects of vaccination.

Stainless-steel vs Single-use: The Vaccines Perspective

History and aims of immunisation. Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8

Expanded Programme on Immunization (EPI)

WHO Recommendations and Guidelines for the Prevention of Perinatal Hepatitis B and Use of Hepatitis B Vaccines

Frequently asked questions (FAQs) on MR vaccination campaign. Training Workshop for Measles-Rubella Vaccination Campaigns

Copyright regulations Warning

Cyprus Experience. Dr. Elena Papamichael Ministry of Health

THIS FORM IS FOR MEDICAL STUDENTS ONLY IMMUNIZATION RECORD

Healthy People 2020 objectives were released in 2010, with a 10-year horizon to achieve the goals by 2020.

Deployment of Combination Vaccines and STI vaccines

EXPANDED PROGRAM OF IMMUNIZATION (EPI) Definition Program adopted by WHO since l974, it includes child immunization & vaccination of pregnant women.

Establishing a cholera stockpile: What do we need? Alejandro Costa Epidemic Readiness and Intervention

Expanded Programme on Immunization (EPI)

Immunizations are among the most cost effective and widely used public health interventions.

Frequently asked questions (FAQs) on MR vaccination campaign

CONTROLLED TEMPERATURE CHAIN:

The Financial Sustainability of New Vaccine Introduction in the Poorest Countries :

VACCINES TRIUMPHS AND TRIBULATIONS. William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine

Vaccines Prevent Illness

Exercise: Estimating immunization program costs (~60 minutes)

Walter A. Orenstein, M.D. Professor of Medicine and Pediatrics Director, Emory Vaccine Policy and Development Associate Director, Emory Vaccine Center

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS

UNICEF Safe Injection Equipment Key highlights

Improving the vaccine supply chain in developing countries via increasing freeze protected cold chain equipment. October, 2014

WHO Guidance Note: Vaccine Diluents

OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE

Table Of Contents Executive Summary Introduction to Vaccines Pediatric Preventive Vaccines

Primary Vaccine Container Roundtable: Modeling

BCG. Program Management. Vaccine Quality

Gavi s Vaccine Investment Strategy

3 rd dose. 3 rd or 4 th dose, see footnote 5. see footnote 13. for certain high-risk groups

Expanded Programme on Immunization (EPI)

Dr. Collins Tabu KPA Conference, 26 th April 2018 Mombasa, Kenya

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100

Expanded Programme on Immunization (EPI)

New Vaccines in SA. Regulatory Perspectives James Southern 2015

CHAPTER ONE: EXECUTIVE SUMMARY. The Global Vaccine Industry CHAPTER TWO: INTRODUCTION TO VACCINES

NHS GRAMPIAN IMMUNISATION PROGRAMMES ANNUAL REPORT 2010/11

Towards the Achievement of GHSA 2024 s Overarching Targets

Hepatitis B prevention in Malaysia

7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids

ECONOMICS OF THE VACCINE MARKET: SIZE, GROWTH AND REVENUES

National Immunization Program: Historical and Contemporary Perspectives

WHO Update Tania Cernuschi & Patrick Lydon

MenA vaccine Introduction Country Experience, Ethiopia

Vaccine Storage and Cold Chain

immunisation in New Zealand

National Vaccine Plan: From Strategy to Implementation

Immunization Update Texas Immunization Conference

ACIP Meeting Update, New Recommendations and Pending Influenza Season

Chapter 23.4 Vaccine Storage and Cold Chain Karan Singh Sagar, Manish Jain. The Childhood Years PART V MORE ON THIS TOPIC

The Cold Chain and Vaccine storage

VACCINATION. DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.

Pentabio Vaccine (DTP-HB-Hib)

Appendix An Assessment Tool to Determine the Validity of Vaccine Doses

Pentavalent Market. UNICEF/UN074464/Lister. UNICEF SUPPLY DIVISION 2018 Vaccine Industry Consultation

7Monitoring and using your data

Immunization Guidelines for the Use of State Supplied Vaccine April 18, 2013

Vaccine Innovation: Challenges and Opportunities to Protect Health. Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines

1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector

Immunization. Historical point

Immunization Guidelines For the Use of State Supplied Vaccine July 1, 2011

RECOMMENDED IMMUNIZATIONS

Transcription:

Vaccine Cold Chain in a Continental Country Brazil GISELE MIRANDA 2018 FLY PHARMA US 11 SEP 2018

Fiocruz / Bio-Manguinhos Part of the MoH 118 years old Biggest health institution in Brazil Presence in 10 states + one country in Africa Focus in public Health Activities: R,D&I Education Health assistance Production and supply of medicines and vaccines Museum

Immunization in Brazil Vaccination against Smallpox since 1804 Mass vaccination against smallpox in Rio de Janeiro in early 1900 Sanitary reform and elimination of cholera, plague, YF and smallpox results: the vaccine uprising

National Immunization Program The success of national vaccination campaign against Smallpox and its erradication in 1971 Establishment of the NIP in 1973 to guarantee the continuity, equity and gratuity Centralized planning and guidance, but shared responsibilities with states and districts

National Immunization Program s Callendar age BCG Hep B DTP-HB - Hib At birth Single dose Birth dose OPV/ IPV Pneumo Rota Men C YF MMR Varicella Hep A Td HPV dtpa Influenza 2 months 1 st dose 1 st dose 1 st dose 1 st dose 3 months 1 st dose 4 months 2 nd dose 2 nd dose 2 nd dose 2 nd dose 5 months 2 nd dose 6 months 3 rd dose 3 rd dose 1 st dose 9 months Single dose 16 different vacines 20 diseases > 37 doses / person 12 months Booster dose 1 st Booster Single dose Single dose 15 months 1 st Booster (DTP) 1 st Booster (OPV) Single dose Booster every year 4 years 2 nd Booster(DTP) 2 nd Booster (OPV) 9 years 2 doses 10 19 3 doses 2 nd Booster Single dose Booster every 10 years years 20 59 years 3 doses Single dose Booster every 10 years 60+ 3 doses Single dose Booster every 10 years Booster every year Pregnant 3 doses 2 doses Single dose

Why is it a big challenge?

Continental country: 8.516.000 km² (US 9.834.000 km²) 5.570 districts 208.7K inhabitants (US 325,7 milhões)

Road infrastructure: 1.720.756 km roads only 12,3% are paved roads

More than 36.000 immunization facilities

Large urban áreas (São Paulo 12.1 million 7th bigger city of the world) X Rural areas (15% in isolated areas)

2018 Population pyramid Large population of children under 4Yrs + 14,8K under 4yrs 26,4K over 60 yrs Growing population over 60ysr men women 2010

A long way to reach one child A journey to an Amazonian village

Vaccine Distribution Scheme Decentralized control of the operations and resources (industry, MoH, States, Districts...) NIP is responsible for the guidance and training Shared responsibilities for the information and planning

Temperature sensitivity of vaccines

Acceptable Acceptable Acceptable WHO recommended vaccine storage temperatures and maximum storage periods National (up to 12 months) Sub-National (up to 6 months) District (up to 3 months) Service (up to 1 months) +8ºC Liquid Lyophil Liquid Lyophil Liquid Lyophil Liquid Lyophil +2ºC All OPV -15ºC All OPV Lyophil All OPV Lyophil All OPV Lyophil -25ºC

Bio-Manguinhos (vaccine manufacturer)

CENADI (Vaccine s National Storage and Distribution Center)

Special cold box design

Sub-national central stores

Going to the last mile

Support from the Brazilian Army

Immunization room - routine

Outreach immunization National Immunization day

Open markets Schools Beaches Parks Churches...

Never loose the opportunity to vaccinate

How to ensure the quality of the service? Right product Right quantity Right condition Right place Right time Right cost

Cold Chain Guidelines - NIP Guidelines of Good Storage and Distribution Practices revised consistently Types and characteristics of each immunobiological Thermodinamics Maintenance of equipments Quality system Safety guidelines Control and monitoring instruments Supply planning tools New Technologies

Preparing the dose Handling the vacines How to administer MDVP Never loose the opportunity to vaccinate

Temperature control devices Temperature mesuring devices Wired digital thermometer Cold room Cold box (transport) Cold box (immunization room) Infrared thermometer Datalogger Fridge tag Freeze tag

CTC a disruptive aproach

Controlled Temperature Chain - CTC An optional method of transporting and storing vaccines in carriers without icepacks up to specific number of days before the vaccines are used Only for campaign or special strategy setting. Support +40 C for a minimum of 3 days and must have: A vaccine vial monitor (VVM) on each vial, and A peak threshold indicator in each vaccine carrier. The vaccine must be licensed for use in a CTC (WHO PQ and NRA)

Why is it useful? Fewer resouces Easier outreach Increased coverage

CTC Pilots in Africa Priority vaccines to be used in CTC: - Human papillomavirus (HPV); - Oral cholera vaccine (OCV); - Tetanus toxoid vaccine - Hepatitis B vaccine birth dose (HepB-BD). Already in use in estern, central and subsaarian africa

New Technologies and approaches Thank you! Gisele Miranda Gisa@bio.fiocruz.br